Lexicon Pharmaceuticals
LXRX
103 hedge funds and large institutions have $813M invested in Lexicon Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
4% less capital invested
Capital invested by funds: $846M → $813M (-$33.2M)
6% less funds holding
Funds holding: 109 → 103 (-6)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.28M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$2.1M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.52M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.11M |
| 5 |
Royal London Asset Management
United Kingdom
|
+$953K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JG
Jefferies Group
New York
|
-$3.81M |
| 2 |
GF
Gabelli Funds
Rye,
New York
|
-$2.51M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.8M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.77M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$554K |
LXRX Hedge Fund Activity: Q1 2014 in Review
103 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q1 2014, worth a combined $813M — down 3.9% from $846M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of LXRX and 8 opened new positions — a net loss of 6 holders — while 32 trimmed existing stakes and 31 added.
The largest buyer was Fidelity Investments, adding an estimated $4.28M. The largest seller was Jefferies Group, exiting entirely with an estimated $3.81M sold.
- 103 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q1 2014, down from 109 in Q4 2013.
- Funds reported $813M of Lexicon Pharmaceuticals stock for Q1 2014, down 3.9% quarter-over-quarter.
- 8 funds opened new Lexicon Pharmaceuticals positions in Q1 2014 and 14 closed out, a net change of -6 holders.
- The largest Lexicon Pharmaceuticals buyer in Q1 2014 was Fidelity Investments, an estimated $4.28M added.
- The largest Lexicon Pharmaceuticals seller in Q1 2014 was Jefferies Group, an estimated $3.81M sold.
Based on aggregated 13F filings for Q1 2014.